BioregulatorResearch
Cartalax
Also known as: Ala-Glu-Asp · AED
A tripeptide bioregulator for cartilage and joint regeneration, rebuilding joint matrix from the inside out.
Reviewed by Dr. Sarah Mitchell, PharmD, BCPS
Lead Researcher · 12+ years in peptide therapeutics
Half-Life
~30 minutes
Typical Dose
10 mg daily (oral, cycled)
Administration
Oral capsule
Mechanism of Action
Epigenetic activation of chondrocyte gene expression for cartilage matrix synthesis and anti-inflammatory protection.
Key Research Areas
bioregulatorcartilagejointsosteoarthritis
Frequently Asked Questions
What is Cartalax?▾
A tripeptide bioregulator for cartilage and joint regeneration, rebuilding joint matrix from the inside out.
How does Cartalax work?▾
Epigenetic activation of chondrocyte gene expression for cartilage matrix synthesis and anti-inflammatory protection.
What is the recommended dosage for Cartalax?▾
The typical research dosage is 10 mg daily (oral, cycled), administered via Oral capsule. Dosage protocols vary by study and should be determined by a qualified healthcare professional.
What is the half-life of Cartalax?▾
The half-life of Cartalax is approximately ~30 minutes. This affects dosing frequency and timing in research protocols.
Is Cartalax FDA approved?▾
Cartalax is currently classified as "Research" and is not FDA approved for general use. It is available for research purposes or through compounding pharmacies depending on your jurisdiction.
Research Disclaimer
The information provided about Cartalax is for educational purposes only and is not intended as medical advice. Always consult a qualified healthcare professional before starting any peptide protocol. Products discussed have not been evaluated by the FDA unless explicitly noted.